{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:55:01Z","timestamp":1789390501742,"version":"build-2803163510"},"reference-count":207,"publisher":"Elsevier","isbn-type":[{"value":"9780128022726","type":"print"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/bs.adgen.2014.10.005","type":"book-chapter","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T18:42:12Z","timestamp":1417718532000},"page":"179-233","source":"Crossref","is-referenced-by-count":149,"title":["Self-Amplifying mRNA Vaccines"],"prefix":"10.1016","author":[{"given":"Luis A.","family":"Brito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Kommareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Uematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Giovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Berlanda Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillis R.","family":"Otten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Mandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Dormitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Geall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/bs.adgen.2014.10.005_bib1","doi-asserted-by":"crossref","first-page":"15107","DOI":"10.1128\/JVI.79.24.15107-15113.2005","article-title":"Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus","volume":"79","author":"Aberle","year":"2005","journal-title":"Journal of Virology"},{"issue":"5480","key":"10.1016\/bs.adgen.2014.10.005_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/252252a0","article-title":"Liposomes as immunological adjuvants","volume":"252","author":"Allison","year":"1974","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbamem.2005.02.001","article-title":"Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression","volume":"1669","author":"Ambegia","year":"2005","journal-title":"Biochimica et Biophysica Acta"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/421999","article-title":"Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee","volume":"39","author":"Arvin","year":"2004","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/bs.adgen.2014.10.005_bib5","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1017\/S1462399408000859","article-title":"Therapeutic and prophylactic applications of alphavirus vectors","volume":"10","author":"Atkins","year":"2008","journal-title":"Expert Reviews in Molecular Medicine"},{"issue":"16","key":"10.1016\/bs.adgen.2014.10.005_bib6","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0264-410X(97)00111-4","article-title":"Effect of IL-4 and IL-12 liposomal formulations on the induction\u00a0of immune response to bovine herpesvirus type-1 glycoprotein D","volume":"15","author":"Baca-Estrada","year":"1997","journal-title":"Vaccine"},{"issue":"155","key":"10.1016\/bs.adgen.2014.10.005_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004414","article-title":"Immunotherapy against HPV16\/18 generates potent TH1 and cytotoxic cellular immune responses","volume":"4","author":"Bagarazzi","year":"2012","journal-title":"Science Translational Medicine"},{"issue":"21","key":"10.1016\/bs.adgen.2014.10.005_bib8","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1007\/s00018-012-0990-9","article-title":"Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements","volume":"69","author":"Barrett","year":"2012","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","article-title":"Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers","volume":"28","author":"Bernstein","year":"2009","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/bs.adgen.2014.10.005_bib10","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1093\/nar\/29.18.3882","article-title":"Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells","volume":"29","author":"Bettinger","year":"2001","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.adgen.2014.10.005_bib206","article-title":"Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a\u00a0Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion","author":"Bogers","year":"2014","journal-title":"Journal of Infetiuos Diseases"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.virol.2004.11.034","article-title":"Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells","volume":"332","author":"Brazzoli","year":"2005","journal-title":"Virology"},{"issue":"6","key":"10.1016\/bs.adgen.2014.10.005_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/1097-0290(20000920)69:6<679::AID-BIT12>3.0.CO;2-6","article-title":"Optimization of repeated-batch transcription for RNA production","volume":"69","author":"Breckenridge","year":"2000","journal-title":"Biotechnology and Bioengineering"},{"issue":"11","key":"10.1016\/bs.adgen.2014.10.005_bib13","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1128\/JVI.67.11.6439-6446.1993","article-title":"Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs","volume":"67","author":"Bredenbeek","year":"1993","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.adgen.2014.10.005_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2014.133","article-title":"A cationic nanoemulsion for the delivery of next generation RNA vaccines","author":"Brito","year":"2014","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.adgen.2014.10.005_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4614-0980-9_8","article-title":"Infection of cells by alphaviruses","volume":"726","author":"Brown","year":"2012","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"4520","key":"10.1016\/bs.adgen.2014.10.005_bib16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/1771124a0","article-title":"Hydrolysis of Esters of Monoribonucleotides","volume":"177","author":"Brown","year":"1956","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib17","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1021\/cr960421s","article-title":"Oxidative nucleobase modifications leading to strand scission","volume":"98","author":"Burrows","year":"1998","journal-title":"Chemical Reviews"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.005_bib18","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1586\/erv.09.84","article-title":"DNA vaccine manufacture: scale and quality","volume":"8","author":"Cai","year":"2009","journal-title":"Expert Review of Vaccines"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.005_bib19","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.vaccine.2010.12.090","article-title":"Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes","volume":"29","author":"Calabro","year":"2011","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/bs.adgen.2014.10.005_bib20","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2013.05.007","article-title":"The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect","volume":"31","author":"Calabro","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1042\/BC20080104","article-title":"Role of 5'- and 3'-untranslated regions of mRNAs in human diseases","volume":"101","author":"Chatterjee","year":"2009","journal-title":"Biology of the Cell"},{"key":"10.1016\/bs.adgen.2014.10.005_bib22","first-page":"125","article-title":"Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169","volume":"154","author":"Chee","year":"1990","journal-title":"Current Topics in Microbiology and Immunology"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.005_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"Cooper","year":"1999","journal-title":"Immunity"},{"issue":"21","key":"10.1016\/bs.adgen.2014.10.005_bib24","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1002\/elps.200700127","article-title":"RNA analysis by MEKC with LIF detection","volume":"28","author":"Cornelius","year":"2007","journal-title":"Electrophoresis"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.20749","article-title":"Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C","volume":"42","author":"Cox","year":"2005","journal-title":"Hepatology"},{"issue":"1\u20132","key":"10.1016\/bs.adgen.2014.10.005_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2010.10.025","article-title":"Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles","volume":"403","author":"Crawford","year":"2011","journal-title":"International Journal of Pharmaceutics"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/vaccines1030367","article-title":"Enhanced delivery and potency of self-amplifying mRNA vaccines by electroporation in situ","volume":"1","author":"Cu","year":"2013","journal-title":"Vaccines"},{"issue":"18","key":"10.1016\/bs.adgen.2014.10.005_bib28","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1093\/nar\/24.18.3647","article-title":"Preparative-scale purification of RNA using an efficient method which combines gel electrophoresis and column chromatography","volume":"24","author":"Cunningham","year":"1996","journal-title":"Nucleic Acids Research"},{"issue":"18","key":"10.1016\/bs.adgen.2014.10.005_bib29","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1093\/nar\/gkm657","article-title":"Identification of recognition residues for ligation-based detection and quantitation of pseudouridine and N6-methyladenosine","volume":"35","author":"Dai","year":"2007","journal-title":"Nucleic Acids Research"},{"issue":"6","key":"10.1016\/bs.adgen.2014.10.005_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/erv.13.46","article-title":"Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases","volume":"12","author":"Dasari","year":"2013","journal-title":"Expert Review of Vaccines"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0958-1669(95)80035-2","article-title":"Large-scale oligoribonucleotide production","volume":"6","author":"Davis","year":"1995","journal-title":"Current Opinion in Biotechnology"},{"issue":"8","key":"10.1016\/bs.adgen.2014.10.005_bib32","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/eji.200838648","article-title":"Alum adjuvanticity: unraveling a century old mystery","volume":"38","author":"De Gregorio","year":"2008","journal-title":"European Journal of Immunology"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.005_bib33","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.addr.2005.01.012","article-title":"The role of particle-mediated DNA vaccines in biodefense preparedness","volume":"57","author":"Dean","year":"2005","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"6","key":"10.1016\/bs.adgen.2014.10.005_bib34","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/17425247.2014.901308","article-title":"Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines","volume":"11","author":"Deering","year":"2014","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.0818-9641.2004.01276.x","article-title":"Effect of incorporation of the adjuvant Quil A on structure and immune stimulatory capacity of liposomes","volume":"82","author":"Demana","year":"2004","journal-title":"Immunology & Cell Biology"},{"issue":"8981","key":"10.1016\/bs.adgen.2014.10.005_bib36","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(95)91691-1","article-title":"Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection","volume":"346","author":"Diepolder","year":"1995","journal-title":"Lancet"},{"issue":"Pt 5","key":"10.1016\/bs.adgen.2014.10.005_bib37","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1099\/vir.0.79888-0","article-title":"Genetic content of wild-type human cytomegalovirus","volume":"85","author":"Dolan","year":"2004","journal-title":"Journal of General Virology"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.aca.2008.02.026","article-title":"Improving CMC-derivatization of pseudouridine in RNA for mass spectrometric detection","volume":"612","author":"Durairaj","year":"2008","journal-title":"Analytica Chimica Acta"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0005-2736(96)00242-8","article-title":"Biophysical characterization of cationic lipid: DNA complexes","volume":"1325","author":"Eastman","year":"1997","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.005_bib40","doi-asserted-by":"crossref","first-page":"e515","DOI":"10.1371\/journal.pntd.0000515","article-title":"Novel vaccines to human rabies","volume":"3","author":"Ertl","year":"2009","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"52","key":"10.1016\/bs.adgen.2014.10.005_bib41","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.1016\/j.vaccine.2012.10.015","article-title":"Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine?","volume":"30","author":"Evans","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<76::AID-JPS8>3.0.CO;2-U","article-title":"Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies","volume":"89","author":"Evans","year":"2000","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.005_bib43","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/annonc\/mdr300","article-title":"Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis","volume":"23","author":"Fasol","year":"2012","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.005_bib44","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/bp990065+","article-title":"Development of process flow sheets for the purification of supercoiled plasmids for gene therapy applications","volume":"15","author":"Ferreira","year":"1999","journal-title":"Biotechnology Progress"},{"issue":"31","key":"10.1016\/bs.adgen.2014.10.005_bib45","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/S0264-410X(03)00504-8","article-title":"Rabies DNA vaccine in the horse: strategies to improve serological responses","volume":"21","author":"Fischer","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nm1353","article-title":"A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees","volume":"12","author":"Folgori","year":"2006","journal-title":"Nature Medicine"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.005_bib47","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1128\/JVI.73.9.7497-7504.1999","article-title":"Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization","volume":"73","author":"Fournillier","year":"1999","journal-title":"Journal of Virology"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3181\/00379727-37-9625","article-title":"Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil","volume":"37","author":"Freund","year":"1937","journal-title":"Experimental Biology and Medicine"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib49","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1086\/315060","article-title":"Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine","volume":"180","author":"Frey","year":"1999","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymeth.2006.05.022","article-title":"Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases","volume":"40","author":"Fuller","year":"2006","journal-title":"Methods"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.005_bib51","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/JVI.76.7.3309-3317.2002","article-title":"Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine","volume":"76","author":"Fuller","year":"2002","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrm2104","article-title":"The highways and byways of mRNA decay","volume":"8","author":"Garneau","year":"2007","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.smim.2013.05.001","article-title":"RNA: the new revolution in nucleic acid vaccines","volume":"25","author":"Geall","year":"2013","journal-title":"Seminars in Immunology"},{"issue":"36","key":"10.1016\/bs.adgen.2014.10.005_bib54","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.005_bib55","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2217\/nnm.12.157","article-title":"Liposome-based delivery system for vaccine candidates: constructing an effective formulation","volume":"7","author":"Giddam","year":"2012","journal-title":"Nanomedicine (Lond)"},{"issue":"39","key":"10.1016\/bs.adgen.2014.10.005_bib56","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1016\/j.vaccine.2013.03.020","article-title":"Clinical development of modified vaccinia virus ankara vaccines","volume":"31","author":"Gilbert","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/bs.adgen.2014.10.005_bib57","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1146\/annurev.biochem.68.1.913","article-title":"eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation","volume":"68","author":"Gingras","year":"1999","journal-title":"Annual Review of Biochemistry"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib58","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/187152612798995000","article-title":"Artificial viruses: exploiting viral trafficking for therapeutics","volume":"12","author":"Glover","year":"2012","journal-title":"Infectious Disorders - Drug Targets"},{"issue":"11","key":"10.1016\/bs.adgen.2014.10.005_bib59","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.4161\/hv.22062","article-title":"What you always needed to know about electroporation based DNA vaccines","volume":"8","author":"Gothelf","year":"2012","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"5645","key":"10.1016\/bs.adgen.2014.10.005_bib60","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"issue":"33","key":"10.1016\/bs.adgen.2014.10.005_bib61","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.0801763105","article-title":"The effect of particle design on cellular internalization pathways","volume":"105","author":"Gratton","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Suppl. 5","key":"10.1016\/bs.adgen.2014.10.005_bib62","doi-asserted-by":"crossref","first-page":"B1","DOI":"10.1016\/S0264-410X(02)00514-5","article-title":"A role for liposomes in genetic vaccination","volume":"20","author":"Gregoriadis","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/bs.adgen.2014.10.005_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","article-title":"Vaccine delivery using nanoparticles","volume":"3","author":"Gregory","year":"2013","journal-title":"Frontiers in Cellular & Infection Microbiology"},{"issue":"11","key":"10.1016\/bs.adgen.2014.10.005_bib64","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1073\/pnas.87.11.4023","article-title":"Interaction and mutual stabilization of the two subunits of vaccinia virus mRNA capping enzyme coexpressed in Escherichia coli","volume":"87","author":"Guo","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4149\/av_2009_02_83","article-title":"Sindbis virus replicon-based DNA vaccine encoding Rabies virus glycoprotein elicits specific humoral and cellular immune response in dogs","volume":"53","author":"Gupta","year":"2009","journal-title":"Acta Virologica"},{"issue":"15","key":"10.1016\/bs.adgen.2014.10.005_bib66","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.gt.3301506","article-title":"On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids","volume":"8","author":"Hafez","year":"2001","journal-title":"Gene Therapy"},{"issue":"8","key":"10.1016\/bs.adgen.2014.10.005_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2013.54","article-title":"Rapidly produced SAM\u00ae vaccine against H7N9 influenza is immunogenic in mice","volume":"2","author":"Hekele","year":"2013","journal-title":"Emerging Microbes & Infections"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib68","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"Journal of Controlled Release"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2012.04592.x","article-title":"Developments in rabies vaccines","volume":"169","author":"Hicks","year":"2012","journal-title":"Clinical & Experimental Immunology"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.005_bib70","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cell.2009.01.019","article-title":"The many pathways of RNA degradation","volume":"136","author":"Houseley","year":"2009","journal-title":"Cell"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.005_bib71","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1073\/pnas.0832180100","article-title":"Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles","volume":"100","author":"Hsu","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.005_bib72","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/jgm.975","article-title":"Interaction of polyamine gene vectors with RNA leads to the dissociation of plasmid DNA-carrier complexes","volume":"8","author":"Huth","year":"2006","journal-title":"Journal of Gene Medicine"},{"key":"10.1016\/bs.adgen.2014.10.005_bib73","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1038\/bcj.2012.6","article-title":"Application of the whole-transcriptome shotgun sequencing approach to the study of Philadelphia-positive acute lymphoblastic leukemia","volume":"2","author":"Iacobucci","year":"2012","journal-title":"Blood Cancer Journal"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib74","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"International Journal of Nanomedicine"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.005_bib75","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/hep.510280429","article-title":"High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C","volume":"28","author":"Ishii","year":"1998","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/bs.adgen.2014.10.005_bib76","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1021\/ja100281x","article-title":"Direct strand scission from a nucleobase radical in RNA","volume":"132","author":"Jacobs","year":"2010","journal-title":"Journal of American Chemical Society"},{"issue":"18","key":"10.1016\/bs.adgen.2014.10.005_bib77","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1093\/nar\/gkm694","article-title":"Surveillance of siRNA integrity by FRET imaging","volume":"35","author":"Jarve","year":"2007","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib78","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11095-004-1873-z","article-title":"A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA","volume":"22","author":"Jeffs","year":"2005","journal-title":"Pharmaceutical Research"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.005_bib79","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/nar\/23.9.1495","article-title":"A Sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo","volume":"23","author":"Johanning","year":"1995","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib80","doi-asserted-by":"crossref","first-page":"e29732","DOI":"10.1371\/journal.pone.0029732","article-title":"Intradermal electroporation of naked replicon RNA elicits strong immune responses","volume":"7","author":"Johansson","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib81","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/COH.0b013e328363d3b7","article-title":"Nonreplicating vectors in HIV vaccines","volume":"8","author":"Johnson","year":"2013","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib82","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2144\/000112593","article-title":"Long-term storage of DNA-free RNA for use in vaccine studies","volume":"43","author":"Jones","year":"2007","journal-title":"Biotechniques"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.005_bib83","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2217\/fmb.09.59","article-title":"A structural and functional perspective of alphavirus replication and assembly","volume":"4","author":"Jose","year":"2009","journal-title":"Future Microbiology"},{"issue":"10","key":"10.1016\/bs.adgen.2014.10.005_bib84","doi-asserted-by":"crossref","DOI":"10.4161\/hv.25181","article-title":"A novel, disruptive vaccination technology: self-adjuvanted RNActive vaccines","volume":"9","author":"Kallen","year":"2013","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib85","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/2051013613508729","article-title":"A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs","volume":"2","author":"Kallen","year":"2014","journal-title":"Therapeutic Advances in Vaccines"},{"issue":"21","key":"10.1016\/bs.adgen.2014.10.005_bib86","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Kariko","year":"2011","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib87","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/med.20090","article-title":"Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises","volume":"27","author":"Karmali","year":"2007","journal-title":"Medicinal Research Reviews"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib88","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4161\/rna.7.2.11468","article-title":"Detection of RNA modifications","volume":"7","author":"Kellner","year":"2010","journal-title":"RNA Biology"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.005_bib89","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of\u00a0congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Reviews in Medical Virology"},{"issue":"10","key":"10.1016\/bs.adgen.2014.10.005_bib90","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.4161\/hv.25272","article-title":"Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses","volume":"9","author":"Kichaev","year":"2013","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib91","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrmicro1326","article-title":"Virus membrane-fusion proteins: more than one way to make a hairpin","volume":"4","author":"Kielian","year":"2006","journal-title":"Nature Reviews Microbiology"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib92","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bulletin of the World Health Organization"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.005_bib93","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1073\/pnas.0307145101","article-title":"Mimicking live flavivirus immunization with a noninfectious RNA vaccine","volume":"101","author":"Kofler","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5373","key":"10.1016\/bs.adgen.2014.10.005_bib94","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.281.5373.78","article-title":"An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery","volume":"281","author":"Koltover","year":"1998","journal-title":"Science"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib95","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1751-1097.1990.tb01793.x","article-title":"Sequence-specificity of the alkali-sensitive lesions induced in DNA by high-intensity ultraviolet laser radiation","volume":"52","author":"Kovalsky","year":"1990","journal-title":"Photochemistry and Photobiology"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib96","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.vaccine.2013.09.042","article-title":"Priorities for CMV vaccine development","volume":"32","author":"Krause","year":"2013","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/bs.adgen.2014.10.005_bib97","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1093\/nar\/12.18.7057","article-title":"Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs","volume":"12","author":"Krieg","year":"1984","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.adgen.2014.10.005_bib98","first-page":"1001","article-title":"Togaviridae: the viruses and their replication","volume":"Vol. 1","author":"Kuhn","year":"2007"},{"issue":"10","key":"10.1016\/bs.adgen.2014.10.005_bib99","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.4161\/hv.25473","article-title":"Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques","volume":"9","author":"Kulkarni","year":"2013","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0378-4347(00)80732-X","article-title":"Quantitative measurement of mRNA cap 0 and cap 1 structures by high-performance liquid chromatography","volume":"378","author":"Kuo","year":"1986","journal-title":"Journal of Chromatography"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib101","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/nar\/gkl948","article-title":"The chemical stability of abasic RNA compared to abasic DNA","volume":"35","author":"Kupfer","year":"2007","journal-title":"Nucleic Acids Research"},{"issue":"10","key":"10.1016\/bs.adgen.2014.10.005_bib102","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nature Reviews Genetics"},{"issue":"8","key":"10.1016\/bs.adgen.2014.10.005_bib103","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/infdis\/jis107","article-title":"Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant","volume":"205","author":"La Rosa","year":"2012","journal-title":"Journal of Infectious Diseases"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.005_bib104","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"Lechner","year":"2000","journal-title":"Journal of Experimental Medicine"},{"issue":"9\u201310","key":"10.1016\/bs.adgen.2014.10.005_bib105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0264-410X(99)00271-6","article-title":"DNA and RNA-based vaccines: principles, progress and prospects","volume":"18","author":"Leitner","year":"1999","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/bs.adgen.2014.10.005_bib106","doi-asserted-by":"crossref","first-page":"18440","DOI":"10.1021\/jp303267y","article-title":"Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core","volume":"116","author":"Leung","year":"2012","journal-title":"Journal of Physical Chemistry C: Nanomater Interfaces"},{"issue":"18","key":"10.1016\/bs.adgen.2014.10.005_bib107","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.gt.3302838","article-title":"Gene therapy progress and prospects: non-viral gene therapy by systemic delivery","volume":"13","author":"Li","year":"2006","journal-title":"Gene Therapy"},{"issue":"49","key":"10.1016\/bs.adgen.2014.10.005_bib108","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1016\/j.vaccine.2012.09.056","article-title":"The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB","volume":"30","author":"Lilja","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.005_bib109","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nbt1291-1356","article-title":"A new generation of animal cell expression vectors based on the Semliki Forest virus replicon","volume":"9","author":"Liljestrom","year":"1991","journal-title":"Biotechnology (N Y)"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib207","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1128\/JVI.02743-07","volume":"82","author":"Lin","year":"2008","journal-title":"Journal of Virology"},{"issue":"11","key":"10.1016\/bs.adgen.2014.10.005_bib110","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/ja01640a004","article-title":"The mechanism of the alkaline hydrolysis of ribonucleic acids","volume":"76","author":"Lipkin","year":"1954","journal-title":"Journal of American Chemical Society"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib111","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","article-title":"DNA vaccines: an historical perspective and view to the future","volume":"239","author":"Liu","year":"2011","journal-title":"Immunological Reviews"},{"issue":"1\u20133","key":"10.1016\/bs.adgen.2014.10.005_bib112","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-3659(01)00494-1","article-title":"Development of non-viral vectors for systemic gene delivery","volume":"78","author":"Liu","year":"2002","journal-title":"Journal of Controlled Release"},{"issue":"17\u201318","key":"10.1016\/bs.adgen.2014.10.005_bib113","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0264-410X(02)00143-3","article-title":"Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers","volume":"20","author":"Lodmell","year":"2002","journal-title":"Vaccine"},{"issue":"2\u20133","key":"10.1016\/bs.adgen.2014.10.005_bib114","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0264-410X(97)88325-9","article-title":"Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection","volume":"16","author":"Lodmell","year":"1998","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/bs.adgen.2014.10.005_bib115","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm0898-949","article-title":"DNA immunization protects nonhuman primates against rabies virus","volume":"4","author":"Lodmell","year":"1998","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1016\/bs.adgen.2014.10.005_bib116","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.vaccine.2012.12.009","article-title":"Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies","volume":"31","author":"Loomis","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib117","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1261\/rna.5264804","article-title":"Large-scale preparation and purification of polyacrylamide-free RNA oligonucleotides","volume":"10","author":"Lukavsky","year":"2004","journal-title":"RNA"},{"issue":"4\u20136","key":"10.1016\/bs.adgen.2014.10.005_bib118","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000053992","article-title":"Alphavirus vectors: applications for DNA vaccine production and gene expression","volume":"43","author":"Lundstrom","year":"2000","journal-title":"Intervirology"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.005_bib119","doi-asserted-by":"crossref","first-page":"e34833","DOI":"10.1371\/journal.pone.0034833","article-title":"Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.005_bib120","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/4031","article-title":"In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model","volume":"4","author":"Mandl","year":"1998","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.adgen.2014.10.005_bib121","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/10_003","article-title":"Plasmid vaccines and therapeutics: from design to applications","volume":"99","author":"Manthorpe","year":"2005","journal-title":"Advances in Biochemical Engineering\/Biotechnology"},{"issue":"39","key":"10.1016\/bs.adgen.2014.10.005_bib122","doi-asserted-by":"crossref","first-page":"24472","DOI":"10.1016\/S0021-9258(19)51108-5","article-title":"Intrinsic RNA (guanine-7) methyltransferase activity of the vaccinia virus capping enzyme D1 subunit is stimulated by the D12 subunit. Identification of amino acid residues in the D1 protein required for subunit association and methyl group transfer","volume":"269","author":"Mao","year":"1994","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.adgen.2014.10.005_bib123","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0092-8674(00)80280-9","article-title":"Cocrystal structure of the messenger RNA 5' cap-binding protein (eIF4E) bound to 7-methyl-GDP","volume":"89","author":"Marcotrigiano","year":"1997","journal-title":"Cell"},{"key":"10.1016\/bs.adgen.2014.10.005_bib124","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1479-0556-4-2","article-title":"Sustained protective rabies neutralizing antibody titers after administration of cationic lipid-formulated pDNA vaccine","volume":"4","author":"Margalith","year":"2006","journal-title":"Genetic Vaccines and Therapy"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.005_bib125","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/eji.1830230749","article-title":"Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA","volume":"23","author":"Martinon","year":"1993","journal-title":"European Journal of Immunology"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib126","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0006-3495(01)76202-9","article-title":"Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes","volume":"80","author":"Maurer","year":"2001","journal-title":"Biophysical Journal"},{"issue":"Suppl. 4","key":"10.1016\/bs.adgen.2014.10.005_bib127","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1093\/cid\/cit587","article-title":"Cytomegalovirus vaccines","volume":"57","author":"McVoy","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"18","key":"10.1016\/bs.adgen.2014.10.005_bib128","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1093\/nar\/12.18.7035","article-title":"Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter","volume":"12","author":"Melton","year":"1984","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib129","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/JVI.01872-07","article-title":"Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus","volume":"82","author":"Meunier","year":"2008","journal-title":"Journal of Virology"},{"issue":"6","key":"10.1016\/bs.adgen.2014.10.005_bib130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2174\/1385272024604934","article-title":"Cleavage and isomerization of RNA phosphodiester bonds: nucleoside Phosphotriesters and chimeric Ribo\/2'-O-Methylribo oligonucleotides as tools for mechanistic studies","volume":"6","author":"Mikkola","year":"2002","journal-title":"Current Organic Chemistry"},{"issue":"21","key":"10.1016\/bs.adgen.2014.10.005_bib131","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1093\/nar\/15.21.8783","article-title":"Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates","volume":"15","author":"Milligan","year":"1987","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.adgen.2014.10.005_bib132","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-62703-113-4_13","article-title":"In vitro transcription of modified RNAs","volume":"941","author":"Moon","year":"2012","journal-title":"Methods in Molecular Biology"},{"issue":"8","key":"10.1016\/bs.adgen.2014.10.005_bib133","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nbt1122","article-title":"Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs","volume":"23","author":"Morrissey","year":"2005","journal-title":"Nature Biotechnology"},{"issue":"30","key":"10.1016\/bs.adgen.2014.10.005_bib134","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1073\/pnas.0804699105","article-title":"Molecular and cellular signatures of human vaccine adjuvants","volume":"105","author":"Mosca","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.adgen.2014.10.005_bib135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0076-6879(07)25002-5","article-title":"Identification of modified residues in RNAs by reverse transcription-based methods","volume":"425","author":"Motorin","year":"2007","journal-title":"Methods in Enzymology"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.005_bib136","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/ja963701y","article-title":"DNA damage from sulfite autoxidation catalyzed by a Nickel(II) peptide","volume":"119","author":"Muller","year":"1997","journal-title":"Journal of American Chemical Society"},{"issue":"29","key":"10.1016\/bs.adgen.2014.10.005_bib137","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59-an innately attractive adjuvant formulation","volume":"30","author":"O'Hagan","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib138","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/erv.12.140","article-title":"The history of MF59((R)) adjuvant: a phoenix that arose from the ashes","volume":"12","author":"O'Hagan","year":"2013","journal-title":"Expert Review of Vaccines"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib139","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/cr960425x","article-title":"Kinetics and mechanisms for the cleavage and isomerization of the phosphodiester bonds of RNA by bronsted acids and bases","volume":"98","author":"Oivanen","year":"1998","journal-title":"Chemical Reviews"},{"issue":"1\u20133","key":"10.1016\/bs.adgen.2014.10.005_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(01)00545-4","article-title":"A cationic sub-micron emulsion (MF59\/DOTAP) is an effective delivery system for DNA vaccines","volume":"79","author":"Ott","year":"2002","journal-title":"Journal of Controlled Release"},{"issue":"8","key":"10.1016\/bs.adgen.2014.10.005_bib141","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/14712598.4.8.1285","article-title":"Messenger RNA-based vaccines","volume":"4","author":"Pascolo","year":"2004","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/bs.adgen.2014.10.005_bib142","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-3-540-72167-3_11","article-title":"Vaccination with messenger RNA (mRNA)","volume":"183","author":"Pascolo","year":"2008","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"4","key":"10.1016\/bs.adgen.2014.10.005_bib143","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/315022","article-title":"A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant","volume":"180","author":"Pass","year":"1999","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib144","first-page":"459","article-title":"Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogma","volume":"4","author":"Payne","year":"2002","journal-title":"Current Opinion in Molecular Therapeutics"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/ol0167715","article-title":"Synthesis and application of a chain-terminating dinucleotide mRNA cap analog","volume":"4","author":"Peng","year":"2002","journal-title":"Organic Letters"},{"issue":"23\u201324","key":"10.1016\/bs.adgen.2014.10.005_bib146","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/S0264-410X(00)00432-1","article-title":"Liposome-mediated DNA vaccination: the effect of vesicle composition","volume":"19","author":"Perrie","year":"2001","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.005_bib147","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib148","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcdb.2004.11.006","article-title":"The implications of structured 5' untranslated regions on translation and disease","volume":"16","author":"Pickering","year":"2005","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib149","first-page":"753","article-title":"Electroporation of RNA stimulates immunity to an encoded reporter gene in mice","volume":"2","author":"Piggott","year":"2009","journal-title":"Molecular Medicine Reports"},{"issue":"5390","key":"10.1016\/bs.adgen.2014.10.005_bib150","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib151","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib152","first-page":"262","article-title":"Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization","volume":"3","author":"Qiu","year":"1996","journal-title":"Gene Therapy"},{"issue":"8","key":"10.1016\/bs.adgen.2014.10.005_bib153","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0264-410X(96)00281-2","article-title":"Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection","volume":"15","author":"Ray","year":"1997","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib154","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/rmv.360","article-title":"Alphavirus vectors and vaccination","volume":"12","author":"Rayner","year":"2002","journal-title":"Reviews in Medical Virology"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib155","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ymthe.2005.03.038","article-title":"Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes","volume":"12","author":"Rejman","year":"2005","journal-title":"Molecular Therapy"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.005_bib156","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/hum.2011.092","article-title":"Genetic immunization with plasmid DNA mediated by electrotransfer","volume":"22","author":"Rochard","year":"2011","journal-title":"Human Gene Therapy"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib157","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/MMBR.59.3.423-450.1995","article-title":"mRNA stability in mammalian cells","volume":"59","author":"Ross","year":"1995","journal-title":"Microbiological Reviews"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.005_bib158","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/mt.2011.102","article-title":"Single-particle tracking as a quantitative microscopy-based approach to unravel cell entry mechanisms of viruses and pharmaceutical nanoparticles","volume":"19","author":"Ruthardt","year":"2011","journal-title":"Molecular Therapy"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib159","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/erv.11.188","article-title":"Technologies for enhanced efficacy of DNA vaccines","volume":"11","author":"Saade","year":"2012","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/bs.adgen.2014.10.005_bib160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-62703-667-2_5","article-title":"Mapping RNA structure in vitro using nucleobase-specific probes","volume":"1086","author":"Sachsenmaier","year":"2014","journal-title":"Methods in Molecular Biology"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.005_bib161","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1261\/rna.2057810","article-title":"Genome-wide analysis of N1-methyl-adenosine modification in human tRNAs","volume":"16","author":"Saikia","year":"2010","journal-title":"RNA"},{"issue":"23","key":"10.1016\/bs.adgen.2014.10.005_bib162","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1021\/ja00128a050","article-title":"Photoinduced DNA cleavage via electron Transfer: demonstration that guanine residues located 5' to guanine are the most electron-donating sites","volume":"117","author":"Saito","year":"1995","journal-title":"Journal of American Chemical Society"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib163","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.coi.2011.03.008","article-title":"Electroporation delivery of DNA vaccines: prospects for success","volume":"23","author":"Sardesai","year":"2011","journal-title":"Current Opinion in Immunology"},{"issue":"1\u20132","key":"10.1016\/bs.adgen.2014.10.005_bib164","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vetmic.2008.10.030","article-title":"Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein","volume":"136","author":"Saxena","year":"2009","journal-title":"Veterinary Microbiology"},{"issue":"Pt 1","key":"10.1016\/bs.adgen.2014.10.005_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/mic.0.049601-0","article-title":"Pre-existing immunity against vaccine vectors\u2013friend or foe?","volume":"159","author":"Saxena","year":"2013","journal-title":"Microbiology"},{"issue":"11","key":"10.1016\/bs.adgen.2014.10.005_bib166","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4161\/rna.22269","article-title":"Developing mRNA-vaccine technologies","volume":"9","author":"Schlake","year":"2012","journal-title":"RNA Biology"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib167","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/14760584.4.3.381","article-title":"Progress toward an elusive goal: current status of cytomegalovirus vaccines","volume":"4","author":"Schleiss","year":"2005","journal-title":"Expert Review of Vaccines"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib168","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1517\/14712598.1.2.177","article-title":"Alphavirus vectors: development and potential therapeutic applications","volume":"1","author":"Schlesinger","year":"2001","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib169","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"1\u20132","key":"10.1016\/bs.adgen.2014.10.005_bib170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","article-title":"Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures","volume":"1510","author":"Semple","year":"2001","journal-title":"Biochimica et Biophysica Acta"},{"issue":"5","key":"10.1016\/bs.adgen.2014.10.005_bib171","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1073\/pnas.53.5.1111","article-title":"Pyrimidine dimers in UV-irradiated poly dI:dC","volume":"53","author":"Setlow","year":"1965","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"10.1016\/bs.adgen.2014.10.005_bib172","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells","volume":"180","author":"Seubert","year":"2008","journal-title":"Journal of Immunology"},{"issue":"4 Pt 2","key":"10.1016\/bs.adgen.2014.10.005_bib173","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0092-8674(76)90128-8","article-title":"Capping of eucaryotic mRNAs","volume":"9","author":"Shatkin","year":"1976","journal-title":"Cell"},{"issue":"41","key":"10.1016\/bs.adgen.2014.10.005_bib174","doi-asserted-by":"crossref","first-page":"16534","DOI":"10.1073\/pnas.1210418109","article-title":"Structural and functional insights into alphavirus polyprotein processing and pathogenesis","volume":"109","author":"Shin","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib175","first-page":"244","article-title":"Non-viral amplification systems for gene transfer: vectors based on alphaviruses","volume":"1","author":"Smerdou","year":"1999","journal-title":"Current Opinion in Molecular Therapy"},{"issue":"Suppl. 1","key":"10.1016\/bs.adgen.2014.10.005_bib176","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/jgm.512","article-title":"Plasmid DNA purification","volume":"6","author":"Stadler","year":"2004","journal-title":"Journal of Gene Medicine"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.005_bib177","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994","volume":"43","author":"Staras","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"6110","key":"10.1016\/bs.adgen.2014.10.005_bib178","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1227919","article-title":"Decoding human cytomegalovirus","volume":"338","author":"Stern-Ginossar","year":"2012","journal-title":"Science"},{"issue":"22","key":"10.1016\/bs.adgen.2014.10.005_bib179","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/S0264-410X(99)00094-8","article-title":"Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device","volume":"17","author":"Tacket","year":"1999","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/bs.adgen.2014.10.005_bib180","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/pharmaceutics5030498","article-title":"Advances in lipid nanoparticles for siRNA delivery","volume":"5","author":"Tam","year":"2013","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib181","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0021-9258(19)52337-7","article-title":"Distribution density of nucleotides within a desoxyribonucleic acid chain","volume":"203","author":"Tamm","year":"1953","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/bs.adgen.2014.10.005_bib182","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/CVI.00031-12","article-title":"Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunity","volume":"19","author":"Uematsu","year":"2012","journal-title":"Clinical and Vaccine Immunology"},{"issue":"6","key":"10.1016\/bs.adgen.2014.10.005_bib183","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1440-1711.2004.01288.x","article-title":"Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines","volume":"82","author":"Vajdy","year":"2004","journal-title":"Immunology & Cell Biology"},{"issue":"8","key":"10.1016\/bs.adgen.2014.10.005_bib184","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1128\/JVI.03412-12","article-title":"Alphavirus genome delivery occurs directly at the plasma membrane in a time- and temperature-dependent process","volume":"87","author":"Vancini","year":"2013","journal-title":"Journal of Virology"},{"issue":"52","key":"10.1016\/bs.adgen.2014.10.005_bib185","doi-asserted-by":"crossref","first-page":"21095","DOI":"10.1073\/pnas.1319784110","article-title":"The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination","volume":"110","author":"Vono","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.adgen.2014.10.005_bib186","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coviro.2014.02.004","article-title":"Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease","volume":"6C","author":"Wang","year":"2014","journal-title":"Current Opinion in Virology"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib187","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrg2484","article-title":"RNA-Seq: a revolutionary tool for transcriptomics","volume":"10","author":"Wang","year":"2009","journal-title":"Nature Reviews Genetics"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib188","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/mt.2012.250","article-title":"Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy","volume":"21","author":"Wang","year":"2013","journal-title":"Molecular Therapy"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib189","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmaid.2011.12.005","article-title":"Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure","volume":"10","author":"Warrell","year":"2012","journal-title":"Travel Medicine and Infectious Disease"},{"key":"10.1016\/bs.adgen.2014.10.005_bib190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.ento.49.061802.123422","article-title":"Venezuelan equine encephalitis","volume":"49","author":"Weaver","year":"2004","journal-title":"Annual Review of Entomology"},{"issue":"Pt 6","key":"10.1016\/bs.adgen.2014.10.005_bib191","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1099\/jmm.0.006064-0","article-title":"An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies","volume":"58","author":"Welch","year":"2009","journal-title":"Journal of Medical Microbiology"},{"issue":"30","key":"10.1016\/bs.adgen.2014.10.005_bib192","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.vaccine.2014.05.004","article-title":"Human cytomegalovirus gH\/gL\/UL128\/UL130\/UL131A complex elicits potently neutralizing antibodies in mice","volume":"32","author":"Wen","year":"2014","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/bs.adgen.2014.10.005_bib193","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1086\/588385","article-title":"Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects","volume":"197","author":"Wloch","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"4949 Pt 1","key":"10.1016\/bs.adgen.2014.10.005_bib194","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.adgen.2014.10.005_bib195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1359-0294(00)00091-1","article-title":"Cationic liposomes and nucleic acids","volume":"6","author":"Woodle","year":"2001","journal-title":"Current Opinion in Colloid & Interface Science"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib196","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10875-008-9267-3","article-title":"Human immune memory to yellow fever and smallpox vaccination","volume":"29","author":"Wrammert","year":"2009","journal-title":"Journal of Clinical Immunology"},{"issue":"6","key":"10.1016\/bs.adgen.2014.10.005_bib197","first-page":"764","article-title":"Synthesis and purification of large amounts of RNA oligonucleotides","volume":"11","author":"Wyatt","year":"1991","journal-title":"Biotechniques"},{"issue":"9","key":"10.1016\/bs.adgen.2014.10.005_bib198","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1021\/mp400190z","article-title":"RNA replicon delivery via lipid-complexed PRINT protein particles","volume":"10","author":"Xu","year":"2013","journal-title":"Molecular Pharmaceutics"},{"issue":"18","key":"10.1016\/bs.adgen.2014.10.005_bib199","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1021\/bi9602019","article-title":"Mechanism of DNA release from cationic liposome\/DNA complexes used in cell transfection","volume":"35","author":"Xu","year":"1996","journal-title":"Biochemistry"},{"issue":"21","key":"10.1016\/bs.adgen.2014.10.005_bib200","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.1021\/ja302363r","article-title":"Rendering protein-based particles transiently insoluble for therapeutic applications","volume":"134","author":"Xu","year":"2012","journal-title":"Journal of American Chemical Society"},{"key":"10.1016\/bs.adgen.2014.10.005_bib201","first-page":"87","article-title":"Hepatitis C virus entry","volume":"369","author":"Zeisel","year":"2013","journal-title":"Current Topics in Microbiology and Immunology"},{"issue":"6","key":"10.1016\/bs.adgen.2014.10.005_bib202","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1261\/rna.7110804","article-title":"Detection and quantitation of RNA base modifications","volume":"10","author":"Zhao","year":"2004","journal-title":"RNA"},{"issue":"16","key":"10.1016\/bs.adgen.2014.10.005_bib203","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/0264-410X(94)90074-4","article-title":"Self-replicating Semliki Forest virus RNA as recombinant vaccine","volume":"12","author":"Zhou","year":"1994","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/bs.adgen.2014.10.005_bib204","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/v2020413","article-title":"RNA replicons - a new approach for influenza virus immunoprophylaxis","volume":"2","author":"Zimmer","year":"2010","journal-title":"Viruses"},{"issue":"7089","key":"10.1016\/bs.adgen.2014.10.005_bib205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature04688","article-title":"RNAi-mediated gene silencing in non-human primates","volume":"441","author":"Zimmermann","year":"2006","journal-title":"Nature"}],"container-title":["Advances in Genetics","Nonviral Vectors for Gene Therapy - Physical Methods and Medical Translation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065266014000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065266014000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T22:00:41Z","timestamp":1650751241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065266014000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9780128022726"],"references-count":207,"URL":"https:\/\/doi.org\/10.1016\/bs.adgen.2014.10.005","relation":{},"ISSN":["0065-2660"],"issn-type":[{"value":"0065-2660","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}